Evaluation of the safety and efficacy of biosimilar recombinant growth hormone in children with growth hormone deficiency: non-inferiority, randomized, parallel, multicentric and Phase III trial.
Zaeri H, Omidvar S, Servatian N, Arefnia S, Khademolreza N, Amini H, Taghavi B, Hashemipour M, Eshraghi P, Ghasemi M, Ghergherehchi R, Maleki E, Moravej H, Noorian S, Soheilipour F, Dalili S, Kharazmi H, Didban A, Akhlaghi A, Ghaznavi S, Shahbazi M.
Zaeri H, et al. Among authors: didban a.
Expert Opin Drug Saf. 2025 Jan;24(1):111-119. doi: 10.1080/14740338.2024.2348576. Epub 2024 May 8.
Expert Opin Drug Saf. 2025.
PMID: 38682328
Clinical Trial.